These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 32809158)

  • 1. Anticoagulant treatment in COVID-19: a narrative review.
    Carfora V; Spiniello G; Ricciolino R; Di Mauro M; Migliaccio MG; Mottola FF; Verde N; Coppola N;
    J Thromb Thrombolysis; 2021 Apr; 51(3):642-648. PubMed ID: 32809158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia?
    El Hasbani G; Taher AT
    Med Hypotheses; 2021 Jul; 152():110621. PubMed ID: 34116360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the COVID-19 thrombotic catastrophe complement-connected?
    Conway EM; Pryzdial ELG
    J Thromb Haemost; 2020 Nov; 18(11):2812-2822. PubMed ID: 32762081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection and thrombotic complications: a narrative review.
    Moschonas IC; Tselepis AD
    J Thromb Thrombolysis; 2021 Jul; 52(1):111-123. PubMed ID: 33449290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence.
    Godino C; Scotti A; Maugeri N; Mancini N; Fominskiy E; Margonato A; Landoni G
    Int J Cardiol; 2021 Feb; 324():261-266. PubMed ID: 33002521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients.
    Parker K; Hamilton P; Hanumapura P; Castelino L; Murphy M; Challiner R; Thachil J; Ebah L
    BMC Nephrol; 2021 Jun; 22(1):224. PubMed ID: 34134645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review.
    Cryer MJ; Farhan S; Kaufmann CC; Jäger B; Garg A; Krishnan P; Mehran R; Huber K
    Clin Appl Thromb Hemost; 2022; 28():10760296221074353. PubMed ID: 35068227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic storm in coronavirus disease 2019: from underlying mechanisms to its management.
    Zebardast A; Latifi T; Shabani M; Hasanzadeh A; Danesh M; Babazadeh S; Sadeghi F
    J Med Microbiol; 2022 Nov; 71(11):. PubMed ID: 36346830
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 Coagulopathy: From Pathogenesis to Treatment.
    Alnima T; Mulder MMG; van Bussel BCT; Ten Cate H
    Acta Haematol; 2022; 145(3):282-296. PubMed ID: 35499460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.
    Gando S; Wada T
    Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.
    Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis in COVID-19.
    Hanff TC; Mohareb AM; Giri J; Cohen JB; Chirinos JA
    Am J Hematol; 2020 Dec; 95(12):1578-1589. PubMed ID: 32857878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytopenia and thrombosis in hospitalized patients with COVID-19.
    Mei H; Luo L; Hu Y
    J Hematol Oncol; 2020 Dec; 13(1):161. PubMed ID: 33261634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19.
    Bahraini M; Dorgalaleh A
    Semin Thromb Hemost; 2022 Feb; 48(1):19-30. PubMed ID: 34695858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population.
    Poh KC; Jia Tay VY; Lin SH; Chee HL; Thangavelautham S
    Singapore Med J; 2022 Jul; 63(7):350-361. PubMed ID: 33264831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
    Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients.
    Vergori A; Pianura E; Lorenzini P; D'Abramo A; Di Stefano F; Grisetti S; Vita S; Pinnetti C; Donno DR; Marini MC; Nicastri E; Ianniello S; Antinori A;
    Ann Med; 2021 Dec; 53(1):295-301. PubMed ID: 33491498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.